COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Fundamental Analysis
FRA:COP - Deutsche Boerse Ag - DE000A288904 - Common Stock - Currency: EUR
Taking everything into account, COP scores 4 out of 10 in our fundamental rating. COP was compared to 12 industry peers in the Health Care Technology industry. There are concerns on the financial health of COP while its profitability can be described as average. COP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year COP was profitable.
COP had a positive operating cash flow in the past year.
Each year in the past 5 years COP has been profitable.
Each year in the past 5 years COP had a positive operating cash flow.
1.2 Ratios
The Return On Assets of COP (1.34%) is comparable to the rest of the industry.
COP's Return On Equity of 4.15% is in line compared to the rest of the industry. COP outperforms 58.33% of its industry peers.
The Return On Invested Capital of COP (3.53%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for COP is below the industry average of 8.76%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.15% | ||
| ROIC | 3.53% |
ROA(3y)2.65%
ROA(5y)3.3%
ROE(3y)7.71%
ROE(5y)9.17%
ROIC(3y)4.07%
ROIC(5y)4.45%
1.3 Margins
COP has a Profit Margin (2.34%) which is comparable to the rest of the industry.
COP's Profit Margin has declined in the last couple of years.
COP has a better Operating Margin (8.13%) than 75.00% of its industry peers.
In the last couple of years the Operating Margin of COP has declined.
COP has a better Gross Margin (83.85%) than 75.00% of its industry peers.
COP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.13% | ||
| PM (TTM) | 2.34% | ||
| GM | 83.85% |
OM growth 3Y-2.61%
OM growth 5Y-10.29%
PM growth 3Y-23.61%
PM growth 5Y-19.42%
GM growth 3Y32.01%
GM growth 5Y16.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COP is destroying value.
COP has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, COP has more shares outstanding
The debt/assets ratio for COP is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that COP is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.77, COP is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of COP is 9.74, which is on the high side as it means it would take COP, 9.74 years of fcf income to pay off all of its debts.
COP has a Debt to FCF ratio of 9.74. This is in the better half of the industry: COP outperforms 66.67% of its industry peers.
COP has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.22, COP is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 9.74 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.68
WACC5.21%
2.3 Liquidity
COP has a Current Ratio of 1.12. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
COP has a Current ratio (1.12) which is in line with its industry peers.
COP has a Quick Ratio of 1.09. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
COP has a Quick ratio (1.09) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The earnings per share for COP have decreased strongly by -45.71% in the last year.
COP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.58% yearly.
COP shows a decrease in Revenue. In the last year, the revenue decreased by -2.19%.
The Revenue has been growing by 9.12% on average over the past years. This is quite good.
EPS 1Y (TTM)-45.71%
EPS 3Y-20.77%
EPS 5Y-13.58%
EPS Q2Q%-40%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y4.02%
Revenue growth 5Y9.12%
Sales Q2Q%0.54%
3.2 Future
Based on estimates for the next years, COP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.19% on average per year.
COP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.95% yearly.
EPS Next Y1.4%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue Next Year2.47%
Revenue Next 2Y2.65%
Revenue Next 3Y2.49%
Revenue Next 5Y0.95%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
COP is valuated quite expensively with a Price/Earnings ratio of 42.46.
The rest of the industry has a similar Price/Earnings ratio as COP.
When comparing the Price/Earnings ratio of COP to the average of the S&P500 Index (25.82), we can say COP is valued expensively.
The Price/Forward Earnings ratio is 12.55, which indicates a correct valuation of COP.
COP's Price/Forward Earnings ratio is rather cheap when compared to the industry. COP is cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of COP to the average of the S&P500 Index (21.76), we can say COP is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.46 | ||
| Fwd PE | 12.55 |
4.2 Price Multiples
75.00% of the companies in the same industry are more expensive than COP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, COP is valued cheaper than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.98 | ||
| EV/EBITDA | 9.09 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)30.24
PEG (5Y)N/A
EPS Next 2Y4.91%
EPS Next 3Y9.19%
5. Dividend
5.1 Amount
With a yearly dividend of 0.23%, COP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.69, COP has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, COP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
5.2 History
The dividend of COP is nicely growing with an annual growth rate of 14.75%!
Dividend Growth(5Y)14.75%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
COP pays out 191.63% of its income as dividend. This is not a sustainable payout ratio.
The dividend of COP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP191.63%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
FRA:COP (5/23/2025, 7:00:00 PM)
22.08
+0.02 (+0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners18.37%
Inst Owner ChangeN/A
Ins Owners53.51%
Ins Owner ChangeN/A
Market Cap1.19B
Analysts56.67
Price Target21.32 (-3.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
Yearly Dividend1
Dividend Growth(5Y)14.75%
DP191.63%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.46 | ||
| Fwd PE | 12.55 | ||
| P/S | 1.03 | ||
| P/FCF | 13.98 | ||
| P/OCF | 8.24 | ||
| P/B | 1.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.09 |
EPS(TTM)0.52
EY2.36%
EPS(NY)1.76
Fwd EY7.96%
FCF(TTM)1.58
FCFY7.16%
OCF(TTM)2.68
OCFY12.13%
SpS21.51
BVpS12.12
TBVpS-12.86
PEG (NY)30.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.15% | ||
| ROCE | 5.85% | ||
| ROIC | 3.53% | ||
| ROICexc | 3.83% | ||
| ROICexgc | 41.76% | ||
| OM | 8.13% | ||
| PM (TTM) | 2.34% | ||
| GM | 83.85% | ||
| FCFM | 7.35% |
ROA(3y)2.65%
ROA(5y)3.3%
ROE(3y)7.71%
ROE(5y)9.17%
ROIC(3y)4.07%
ROIC(5y)4.45%
ROICexc(3y)4.31%
ROICexc(5y)4.74%
ROICexgc(3y)36.56%
ROICexgc(5y)51.39%
ROCE(3y)6.74%
ROCE(5y)7.38%
ROICexcg growth 3Y-23.91%
ROICexcg growth 5Y-9.04%
ROICexc growth 3Y-4.3%
ROICexc growth 5Y-14.26%
OM growth 3Y-2.61%
OM growth 5Y-10.29%
PM growth 3Y-23.61%
PM growth 5Y-19.42%
GM growth 3Y32.01%
GM growth 5Y16.44%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 9.74 | ||
| Debt/EBITDA | 3.86 | ||
| Cap/Depr | 52.61% | ||
| Cap/Sales | 5.11% | ||
| Interest Coverage | 2.54 | ||
| Cash Conversion | 69.81% | ||
| Profit Quality | 314.42% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.77 |
F-Score6
WACC5.21%
ROIC/WACC0.68
Cap/Depr(3y)60.99%
Cap/Depr(5y)64.22%
Cap/Sales(3y)5.98%
Cap/Sales(5y)6.31%
Profit Quality(3y)175.79%
Profit Quality(5y)158.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-45.71%
EPS 3Y-20.77%
EPS 5Y-13.58%
EPS Q2Q%-40%
EPS Next Y1.4%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y4.02%
Revenue growth 5Y9.12%
Sales Q2Q%0.54%
Revenue Next Year2.47%
Revenue Next 2Y2.65%
Revenue Next 3Y2.49%
Revenue Next 5Y0.95%
EBIT growth 1Y-18.88%
EBIT growth 3Y1.31%
EBIT growth 5Y-2.11%
EBIT Next Year77.58%
EBIT Next 3Y24.98%
EBIT Next 5Y17.79%
FCF growth 1Y3.01%
FCF growth 3Y-11.08%
FCF growth 5Y-0.24%
OCF growth 1Y-8.49%
OCF growth 3Y-7.96%
OCF growth 5Y3.13%